oral glp-1 agonists Peptide receptor agonists: From injection to delivery strategies The Impact of GLP-1 Receptor

Although in vivo testing to determine the safety and efficacy of JWU-A021 still remains to be achieved, cyclohepta[ b ]indoles based on the structure of JWU-A021 might find a role in therapeutics as a new class of GLP-1 secretagogues

Thus, these trials are not thoroughly discussed in this review

However, long-term studies specific to addiction treatment are required to confirm their safety in this new application

[DOI] [PMC free article] [PubMed] [Google Scholar] 172.Nguyen H., Dufour R., Caldwell-Tarr A

Takashi Enjoji for digital PCR

Nausea tops the list of GLP-1-related stomach issues, affecting 40-70% of patients [2]